MedTrace Logo

Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes

NCT04047537 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2022-05-06

No results posted yet for this study

Summary

This 12 week placebo-controlled study evaluates the safety and impact of 2 different strengths of the medical food formulation WBF-0011.

Conditions

Interventions

OTHER

Medical Food Formulation 1

WBF-0011

OTHER

Medical Food Formulation 2

WBF-0011 (0.2X concentration)

OTHER

Placebo

Placebo Capsules identical to those containing Formulation 1 and 2

Sponsors & Collaborators

  • Pendulum Therapeutics

    lead INDUSTRY

Principal Investigators

  • Orville Kolterman, MD · Whole Biome

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-06
Primary Completion
2020-04-15
Completion
2020-05-30

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04047537 on ClinicalTrials.gov